These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3435956)

  • 1. Solanum alkaloids as inhibitors of enzymatic conversion of dihydrolanosterol into cholesterol.
    Kusano G; Takahashi A; Nozoe S; Sonoda Y; Sato Y
    Chem Pharm Bull (Tokyo); 1987 Oct; 35(10):4321-3. PubMed ID: 3435956
    [No Abstract]   [Full Text] [Related]  

  • 2. Oxygenated sterols as inhibitors of enzymatic conversion of dihydrolanosterol into cholesterol.
    Sato Y; Sonoda Y; Morisaki M; Ikekawa N
    Chem Pharm Bull (Tokyo); 1984 Aug; 32(8):3305-8. PubMed ID: 6518607
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro effects of oxygenated lanosterol derivatives on cholesterol biosynthesis from 24,25-dihydrolanosterol.
    Sonoda Y; Sekigawa Y; Sato Y
    Chem Pharm Bull (Tokyo); 1988 Mar; 36(3):966-73. PubMed ID: 3409414
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibitory effect of 15-oxygenated sterols on cholesterol synthesis from 24,25-dihydrolanosterol.
    Morisaki M; Sonoda Y; Makino T; Ogihara N; Ikekawa N; Sato Y
    J Biochem; 1986 Feb; 99(2):597-600. PubMed ID: 3700366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ganoderic acid and its derivatives as cholesterol synthesis inhibitors.
    Komoda Y; Shimizu M; Sonoda Y; Sato Y
    Chem Pharm Bull (Tokyo); 1989 Feb; 37(2):531-3. PubMed ID: 2743504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of oxygenated lanosterol analogs on cholesterol biosynthesis from lanosterol.
    Sonoda Y; Sato Y
    Chem Pharm Bull (Tokyo); 1983 May; 31(5):1698-701. PubMed ID: 6616720
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of lanosterol analogs on cholesterol biosynthesis from lanosterol.
    Sato Y; Sonoda Y
    Chem Pharm Bull (Tokyo); 1981 Sep; 29(9):2604-9. PubMed ID: 7349280
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of 32-oxygenated lanosterol derivatives on 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and cholesterol biosynthesis from 24,25-dihydrolanosterol.
    Sonoda Y; Obi N; Onoda M; Sakakibara Y; Sato Y
    Chem Pharm Bull (Tokyo); 1992 Oct; 40(10):2796-9. PubMed ID: 1464112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pathway for the conversion of dihydroagnosterol into cholesterol in rat liver.
    Tavares IA; Munday KA; Wilton DC
    Biochem J; 1977 Jul; 166(1):11-5. PubMed ID: 901410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspergillus oryzae produces compounds inhibiting cholesterol biosynthesis downstream of dihydrolanosterol.
    Hajjaj H; Duboc P; Fay LB; Zbinden I; Macé K; Niederberger P
    FEMS Microbiol Lett; 2005 Jan; 242(1):155-9. PubMed ID: 15621432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of cholesterol biosynthesis by carbon monoxide: accumulation of lanosterol and 24,25-dihydrolanosterol.
    Gibbons GF; Mitropoulos KA
    Biochem J; 1972 Mar; 127(1):315-7. PubMed ID: 5073750
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis of lanosterol analogs with lengthened side chains and their effects on cholesterol biosynthesis from lanosterol.
    Sato Y; Sonoda Y
    Chem Pharm Bull (Tokyo); 1984 May; 32(5):1912-8. PubMed ID: 6467473
    [No Abstract]   [Full Text] [Related]  

  • 13. Metabolism of 27-nor-24,25-dihydrolanosterol and 23,24,25,26,27-pentanordihydrolanosterol by rat liver homogenate preparations.
    Sato Y; Sonoda Y
    Chem Pharm Bull (Tokyo); 1982 Feb; 30(2):628-34. PubMed ID: 7094149
    [No Abstract]   [Full Text] [Related]  

  • 14. Oxidative metabolism of cholesterol precursors: sensitivity to ketoconazole, an inhibitor of cytochrome P-450.
    Iglesias J; Gibbons GF
    Steroids; 1989; 53(3-5):311-28. PubMed ID: 2799848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cholesterol analogs on cholesterol biosynthesis from lanosterol.
    Sato Y; Sonoda Y; Morisaki M; Ikekawa N
    Chem Pharm Bull (Tokyo); 1983 May; 31(5):1765-7. PubMed ID: 6616726
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of 26-oxygenosterols from Ganoderma lucidum and their activity as cholesterol synthesis inhibitors.
    Hajjaj H; Macé C; Roberts M; Niederberger P; Fay LB
    Appl Environ Microbiol; 2005 Jul; 71(7):3653-8. PubMed ID: 16000773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4,4'-dimethylcholesta-7,9,14-trienol is an intermediate in the demethylation of dihydroagnosterol.
    Tavares IA; Munday KA; Wilton DC
    Biochem J; 1977 Jul; 166(1):17-20. PubMed ID: 20077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective inhibition of mammalian lanosterol 14 alpha-demethylase by RS-21607 in vitro and in vivo.
    Swinney DC; So OY; Watson DM; Berry PW; Webb AS; Kertesz DJ; Shelton EJ; Burton PM; Walker KA
    Biochemistry; 1994 Apr; 33(15):4702-13. PubMed ID: 8161528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different substrate specificities of lanosterol 14a-demethylase (P-45014DM) of Saccharomyces cerevisiae and rat liver for 24-methylene-24,25-dihydrolanosterol and 24,25-dihydrolanosterol.
    Aoyama Y; Yoshida Y
    Biochem Biophys Res Commun; 1991 Aug; 178(3):1064-71. PubMed ID: 1872829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lymphatic absorption of dihydrolanosterol and cholesterol in the rat.
    Satchithanandam S; Gallo LL; Vahouny GV; Kritchevsky D
    Res Commun Mol Pathol Pharmacol; 1999 Jan; 103(1):91-100. PubMed ID: 10440574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.